Loading...

Metastatic breast cancer: Endocrine therapy landscape reshaped

Endocrine therapy (ET) of hormone receptor (HR)-positive and human epidermal growth factor receptor 2-(HER2)-negative metastatic breast cancer (MBC) historically focused on estrogen deprivation and antagonism. The identification of several intracellular pathways promoting resistance to antiestrogen...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Avicenna J Med
Main Authors: Salkeni, Mohamad Adham, Hall, Samantha June
Format: Artigo
Sprog:Inglês
Udgivet: Medknow Publications & Media Pvt Ltd 2017
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5655644/
https://ncbi.nlm.nih.gov/pubmed/29119080
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/ajm.AJM_20_17
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!